Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05479721 · ClinicalTrials.gov registry record
LITMUS Imaging Study
A clinical trial of NASH - Nonalcoholic Steatohepatitis and NAFLD, sponsored by University of Oxford.
- Active
- Registry status
- 450
- Enrollment target
- 18
- Study locations
NCT05479721 is a study of NASH - Nonalcoholic Steatohepatitis and NAFLD that is active but no longer recruiting, run by University of Oxford. The registered enrollment target is 450 participants, above the 252-participant average among 27 other NASH - Nonalcoholic Steatohepatitis trials with a reported enrollment target (79% higher). The trial reports 18 study locations across 2 states.
The verdict
NCT05479721, a study of NASH - Nonalcoholic Steatohepatitis and NAFLD, is active but no longer recruiting, sponsored by University of Oxford.
- ACTIVE NOT RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 18
- Study locations
Study Summary
The LITMUS Imaging Study is a prospectively recruited, observational study of patients with histologically characterised non-alcoholic fatty liver disease (NAFLD). It aims to evaluate the diagnostic performance of imaging biomarkers (ultrasound elastography and magnetic resonance biomarkers) against NAFLD histological scores in a cross-sectional analysis and the natural history of NAFLD in a longitudinal study.
Conditions Studied
Study Locations (18)
Other
- Helsinki University Hospital - Helsinki
- Le Centre de Recherche Clinique (CRC) du CHU d'Angers - Angers
- Institut ICAN - Institute of Cardiometabolism And Nutrition Hôpital de la Pitié Salpêtrière - Paris
- UNIVERSITÄTSMEDIZIN der Johannes Gutenberg Universität Mainz - Mainz
- Universitätsklinikums Würzburg - Würzburg
- Laiko General Hospital of Athens - Athens
- Università di Palermo - Palermo
- Department of Medical Sciences University of Torino - Torino
- Vall d'Hebron University Hospital - Barcelona
- Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocío University Hospital - Seville
- HU Clínico de Valladolid - Valladolid
- Linköping University Hospital - Linköping
- Inselspital, University Hospital - Bern
- Addenbrookes Hospital - Cambridge
- The Newcastle Upon Tyne Hospitals Nhs Foundation Trust - Newcastle upon Tyne
- Queens Medical Centre - Nottingham
- Oxford University Hospitals NHS Foundation Trust - Oxford
Texas
- Pinnacle Clinical Research - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2019-09-04 |
| Est. Completion | 2025-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05479721
The ClinicalTrials.gov registry entry for NCT05479721 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 252-participant average among 27 other NASH - Nonalcoholic Steatohepatitis trials with a reported enrollment target (79% higher). The listed sponsor is University of Oxford, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with NASH - Nonalcoholic Steatohepatitis appearing as the primary indexed condition, and to 0 interventions.
NCT05479721 reports 18 study locations spanning 2 distinct geographic areas - top geographies include Other, Texas.
Frequently Asked Questions
What is clinical trial NCT05479721 about?
NCT05479721 is a clinical study titled "LITMUS Imaging Study". The LITMUS Imaging Study is a prospectively recruited, observational study of patients with histologically characterised non-alcoholic fatty liver disease (NAFLD). It aims to evaluate the diagnostic performance of imaging biomarkers (ultrasound elastography and magnetic resonance biomarkers) against...
What is the current status of trial NCT05479721?
This trial is currently active not recruiting. The enrollment target is 450 participants. The study started on 2019-09-04. Estimated completion is 2025-10-31.
What conditions does trial NCT05479721 study?
This clinical trial studies the following conditions: NASH - Nonalcoholic Steatohepatitis, NAFLD, NASH, Fibrosis, Liver, Steatosis of Liver.
Who is sponsoring clinical trial NCT05479721?
This trial is sponsored by University of Oxford, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05479721 being conducted?
This trial has 18 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NASH - Nonalcoholic Steatohepatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
RECRUITING
-
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
RECRUITING · NA
-
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
RECRUITING · NA
-
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
RECRUITING · Phase 3
-
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
RECRUITING · Phase 3
-
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.